Search alternatives:
values decrease » values increased (Expand Search), largest decrease (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
ct cases » c2 cases (Expand Search), chd cases (Expand Search), ckd cases (Expand Search)
ad cases » all cases (Expand Search), 19 cases (Expand Search), _ cases (Expand Search)
i values » _ values (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
Showing 81 - 100 results of 26,164 for search '(((( c large decrease ) OR ( ((ct cases) OR (ad cases)) increased ))) OR ( i values decrease ))', query time: 1.09s Refine Results
  1. 81
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  2. 82
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  3. 83
    Same as Fig 2A but for DENV 3, without fine resolution added.

    Same as Fig 2A but for DENV 3, without fine resolution added. by Shaowei Sang (520418)

    Published 2021
    Save to List
    Saved in:
  4. 84
    Species occurrence along the NO₃¯ gradient (sorted by decreasing 25th percentile values).

    Species occurrence along the NO₃¯ gradient (sorted by decreasing 25th percentile values). by Willem Kaijser (12872371)

    Published 2022
    Save to List
    Saved in:
  5. 85
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  6. 86
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  7. 87
    Mean values of “I feel bored” item.

    Mean values of “I feel bored” item. by Ezel Üsten (16548547)

    Published 2023
    Save to List
    Saved in:
  8. 88
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  9. 89
    Refinement of scrambles, with no USM decreases.

    Refinement of scrambles, with no USM decreases. by Jedediah M. Singer (10331212)

    Published 2022
    Save to List
    Saved in:
  10. 90
    Determination of p-values by permutation tests.

    Determination of p-values by permutation tests. by Sarah A. Johnson (11355817)

    Published 2021
    Save to List
    Saved in:
  11. 91
    S1 File -

    S1 File - by Naomasa Okimoto (18784343)

    Published 2024
    “…In the derivation set, the mean CT value of the upper gastrointestinal contents was 48.2 Hounsfield units (HU) and 22.8 HU in cases with and without UGIB. …”
    Save to List
    Saved in:
  12. 92
    Increases and decreases in resources.

    Increases and decreases in resources. by Guangliang Li (194029)

    Published 2024
    Save to List
    Saved in:
  13. 93
    Under-five, post-neonatal and child mortality among children admitted to pediatrics ward of Asella Teaching and Referral Hospital, January 2020 G.C.

    Under-five, post-neonatal and child mortality among children admitted to pediatrics ward of Asella Teaching and Referral Hospital, January 2020 G.C. by Firaol Lemessa Kitila (11402219)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  14. 94
    The COVID-Net redesign for improved CT classification.

    The COVID-Net redesign for improved CT classification. by Xinpa Ying (18599012)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 95
    Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade

    Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade by Serisha D. Naicker (8648370)

    Published 2020
    Save to List
    Saved in:
  16. 96
    The variation trend of |BD| value with age: With the increase of age, the |BD| values decreased significantly (p<0.01).

    The variation trend of |BD| value with age: With the increase of age, the |BD| values decreased significantly (p<0.01). by Yunmeng Da (707943)

    Published 2024
    Save to List
    Saved in:
  17. 97
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  18. 98
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  19. 99
    TITAN decreaser diatom heatmap.

    TITAN decreaser diatom heatmap. by Brent J. Bellinger (21156150)

    Published 2025
    Save to List
    Saved in:
  20. 100
    The decrease in embryonic survival after stress coincides with a decrease in oocyte and embryo size.

    The decrease in embryonic survival after stress coincides with a decrease in oocyte and embryo size. by Sarah Fausett (11812818)

    Published 2021
    Save to List
    Saved in:

Search Tools: